<DOC>
	<DOCNO>NCT02002286</DOCNO>
	<brief_summary>This study pilot study evaluate impact Tripterygium Wilfordii Hook F ( TwHF ) T cell immune activation immune activation HIV-infected immunological non-responders . The investigator aim evaluate safety efficacy profile TwHF HIV immunological non-responders .</brief_summary>
	<brief_title>Safety Efficacy Study TwHF HIV Patients With Poor Immune Responses</brief_title>
	<detailed_description>The investigator recruit 23 patient Peking Union Medical College Hospital Outpatient clinic . They immunological non-responders . Nineteen patient receive Triptolide wilfordii Hook F extract ( 10mg tid po ) plus current cART , 4 patient continue current cART . This study last 12 month . Patients follow month 0 , 3 , 6 , 9 , 12 . During follow-up time point , adverse effect , T cell subset , T cell activation marker routine test order . The investigator hypothesis TwHF might boost CD4 cell recovery reduce immune activation .</detailed_description>
	<criteria>Continuous antiretroviral therapy &gt; 18 month , consistent HIVRNA &lt; 40 copies/mL 12 month ; 1865 year old ; Male female ; Good adherence promise followup ; Inform Consent sign ; CD4 T cell less 300/ul . Active opportunistic infection ( stable within 4 week 2 week ) AIDSrelated carcinoma ; Hemoglobin ( HGB ) &lt; 9 g/dl , white blood cell ( WBC ) &lt; 2000/ul , granulin ( GRN ) &lt; 1000 /ul , platelet ( PLT ) &lt; 75000 /ul , Cr &gt; 1.5x ULN , ALT AST alkaline phosphatase ( ALP ) &gt; 3x upper limit normal ( ULN ) , total bilirubin ( TBIL ) &gt; 2x ULN , creatine kinase ( CK ) &gt; 2x ULN ; Pregnant breastfeed woman woman pregnancy plan ; Active druguser ; Severe neurological defect ; Active alcohol abuse ; Severe gastrointestinal ulcer . Endstage disease cirrhosis , chronic obstructive pulmonary disease , congestive heart failure , recent myocardial ischemia , tumor , etc Those undertaking steroid , immunomodulator , antiinflammatory agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>HIV-infected immunological non-responders</keyword>
	<keyword>Tripterygium Wilfordii Hook F</keyword>
	<keyword>Immune activation</keyword>
</DOC>